Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KHC vs GSK✓SelectedUSD · GSKKHC vs GSK performance historyLatest closeAs of+0.16%11/17
Stock and ETF performance explorer

KHC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-11.6%
GSK return
+43.9%
Excess return
-55.5%
Maximum drawdown
-41.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.2%-2.3%+2.5%+0.7%
7D+3.6%-3.0%+6.6%+4.3%
30D+6.0%+0.4%+5.7%+6.0%
3M+3.1%-1.2%+4.3%+3.3%
6M+13.3%+0.9%+12.4%+13.0%
YTD+8.9%+4.0%+4.9%+7.3%
1Y+9.6%+7.3%+2.3%+7.1%
3Y-11.8%+57.1%-68.9%-21.7%
5Y-11.6%+43.0%-54.6%-22.0%
All-11.6%+43.9%-55.5%-22.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling